Μετάβαση στο περιεχόμενο
Global sound
The Bio Report

The Bio Report

Developing an Off-the-Shelf Cell-Based Immunotherapy for Metastatic Breast Cancer

· 41 λεπ. · Επεισόδιο 200

Σημειώσεις επεισοδίου

For patients with metastatic breast cancer, successive treatments can lose effectiveness as tumors evolve and resistant cancer cells survive, leaving those who have received multiple therapies with limited options. BriaCell is seeking to address that problem with an experimental, off-the-shelf, cell-based immunotherapy designed to stimulate the immune system against multiple cancer-associated targets rather than a single target. Its lead candidate, Bria-IMT, is being studied in combination with a checkpoint inhibitor in a phase 3 trial, while its next-generation programs aim to offer personalized treatment using off-the-shelf cells. William Williams, CEO of BriaCell, discusses how its therapies work, what earlier clinical findings suggest, and the development path forward.

Ιστότοπος: thebioreport.podbean.com

Ζωντανά, τελευταία ώρα: 16.437 τραγούδια σε 7.368 σταθμούς σε 143 χώρες

Ανακαλύψτε τον κόσμο μέσα από το ραδιόφωνο

Περισσότεροι τρόποι ανακάλυψης (9)

Ακούσατε κάτι ωραίο; Αποθηκεύστε το ή ανοίξτε το απευθείας στο Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
WNAPΣυνέχεια ακρόασης